ES
MARKETS / NYSE / OHI
NYSE · REAL ESTATE INVESTMENT TRUSTS · LARGE CAP

Omega Healthcare Investors, Inc. OHI

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.2B
▲ 13.2% vs FY2024
EPS · FY25
$1.94
Dividend / sh · FY25
$2.68
Payout · FY25
132%
ROE · FY25
12.1%
Net margin · FY25
49.6%
Dividend coverage
0.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.2B
Revenue, FY2025 · full 18-year series below
Revenue Net income
0.40.81.21.20.62008201120142017202020232025
0.40.81.21.20.62016201920222025

50 cents of every revenue dollar became profit this year.

Per share
USD 1.94
Diluted EPS, FY2025
EPS Dividend
1232.681.942008201120142017202020232025
1232.681.942016201920222025

Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.

Profitability
12.1%
Return on equity, FY2025
ROE
510152012.1%2008201120142017202020232025
510152012.1%2016201920222025
Operating margin52.5%
Net margin49.6%
Return on assets5.9%

Each USD of equity produced 12 cents of profit this year.

Returned to shareholders
USD 780.4M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 780.4M
Net buybacks—
Share of profit132.2%
Consecutive raises—

USD 780.4M in dividends — 132% of the year's profit, so the payout drew on cash built up earlier.

Growth
+5.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.7%
+5.9%
Net income
+10.4%
+29.3%
+10.1%
+16.7%
EPS, diluted
+2.5%
+22.6%
+4.2%
+9.2%
Dividend / share
+0.0%
+0.0%
+2.1%
+4.6%
Returned to shareholders
+0.2%
+5.0%
+8.1%
+12.2%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.30B
Shares outstanding, FY2025
0.080.302008201120142017202020232025
0.200.302016201920222025
Change, 5 years+27.8%
Change, 10 years+57.7%

The share count grew 28% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.0B
total assets, end of FY2025
Total assetsUSD 10.0B
EquityUSD 5.2B
CashUSD 27.0M
Gross debtUSD 4.3B
Net debtUSD 4.2B

Net debt stands at 82% of equity.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
1.2
1.1
0.9
0.9
1.1
0.9
0.9
0.9
0.9
0.9
·
·
·
·
·
·
·
·
Operating income $B
0.6
0.4
0.3
·
·
·
0.6
0.5
0.3
0.6
0.4
0.3
0.3
0.2
0.1
0.1
0.1
0.1
EBITDA $B
0.9
0.7
0.6
·
·
·
0.9
0.8
0.6
0.8
0.6
0.5
0.4
0.3
0.2
0.2
0.2
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
0.0
0.0
−0.0
Net income $B
0.6
0.4
0.2
0.4
0.4
0.2
0.4
0.3
0.1
0.4
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
EPS, diluted $
1.94
1.55
1.00
1.80
1.75
0.70
1.58
1.40
0.51
1.90
1.29
1.74
1.46
1.12
0.46
0.52
0.87
0.94
Dividend / sh $
2.68
2.68
2.68
2.68
2.68
2.68
2.65
2.64
2.54
2.36
2.18
2.02
1.86
1.69
1.55
1.37
1.20
1.19
Payout %
132
169
266
144
149
374
160
180
479
118
160
117
126
151
308
238
133
126
ROE %
12.1
10.0
6.7
11.7
11.1
4.1
9.3
8.4
2.8
10.1
8.7
16.4
14.9
12.8
5.6
6.3
9.9
9.9
Shares out B
0.30
0.28
0.25
0.23
0.24
0.23
0.23
0.20
0.20
0.20
0.19
0.13
0.12
0.11
0.10
0.10
0.09
0.08

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
35 of 35
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed